COMMUNIQUÉS West-GlobeNewswire

-
Microbot Medical Partners with Baptist Hospital of Miami to Participate in its Pivotal Human Clinical Trial
03/07/2024 -
Evaxion Reinforces Milestone Timeline and Provides Shareholder Update
03/07/2024 -
Spectral AI Expands Clinical Trial Sites for Pivotal U.S. Burn Study
03/07/2024 -
The Canadian Dermatology Association Announces 2024 Award Recipients
03/07/2024 -
L’Association canadienne de dermatologie annonce les lauréats de ses prix de 2024
03/07/2024 -
BC Platforms Announces Appointment of New Chairman, Alex Dickinson
03/07/2024 -
Immutep Announces Details for Oral Presentation at ESMO Virtual Plenary Session and Webcast to Discuss Clinical Results
03/07/2024 -
Apollomics Announces Updated Strategic Focus and Leadership Team Changes
03/07/2024 -
IntelGenx Obtains Preliminary Efficacy Results for the ‘BUENA’ Montelukast VersaFilm® Phase 2a Clinical Trial in Patients with Mild to Moderate Alzheimer’s Disease
03/07/2024 -
Olink® Introduces Global Network of Certified Service Providers to Accelerate Protein Biomarker Discovery
03/07/2024 -
CorMedix Inc. Announces Outpatient Availability of DefenCath
03/07/2024 -
Skye Bioscience Appoints Dr. Karen Smith to Board of Directors
03/07/2024 -
Lifeward Announces Appointment of Joseph E. Turk as Incoming Chairman of its Board of Directors
02/07/2024 -
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02/07/2024 -
Certara to Report Second Quarter 2024 Financial Results on August 6th, 2024
02/07/2024 -
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02/07/2024 -
Avid Bioservices Reports Financial Results for Fourth Quarter and Fiscal Year Ended April 30, 2024
02/07/2024 -
Cartesian Therapeutics Strengthens Board of Directors with Appointment of Kemal Malik
02/07/2024 -
BrightSpring Health Services, Inc. to Announce Second Quarter 2024 Financial Results on August 2, 2024
02/07/2024
Pages